JP2022553703A5 - - Google Patents
Info
- Publication number
- JP2022553703A5 JP2022553703A5 JP2022523575A JP2022523575A JP2022553703A5 JP 2022553703 A5 JP2022553703 A5 JP 2022553703A5 JP 2022523575 A JP2022523575 A JP 2022523575A JP 2022523575 A JP2022523575 A JP 2022523575A JP 2022553703 A5 JP2022553703 A5 JP 2022553703A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926914P | 2019-10-28 | 2019-10-28 | |
| US62/926,914 | 2019-10-28 | ||
| US202063094170P | 2020-10-20 | 2020-10-20 | |
| US63/094,170 | 2020-10-20 | ||
| PCT/US2020/057635 WO2021086899A1 (en) | 2019-10-28 | 2020-10-28 | Anti-hemagglutinin antibodies and methods of use thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022553703A JP2022553703A (ja) | 2022-12-26 |
| JPWO2021086899A5 JPWO2021086899A5 (https=) | 2023-09-26 |
| JP2022553703A5 true JP2022553703A5 (https=) | 2023-09-26 |
| JP7611908B2 JP7611908B2 (ja) | 2025-01-10 |
Family
ID=73498317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523575A Active JP7611908B2 (ja) | 2019-10-28 | 2020-10-28 | 抗血球凝集素抗体およびその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11773156B2 (https=) |
| EP (1) | EP4051707A1 (https=) |
| JP (1) | JP7611908B2 (https=) |
| KR (1) | KR20220088446A (https=) |
| CN (1) | CN114761428A (https=) |
| AU (2) | AU2020374878B2 (https=) |
| BR (1) | BR112022007923A2 (https=) |
| CA (1) | CA3153944A1 (https=) |
| CL (1) | CL2022001067A1 (https=) |
| CO (1) | CO2022005281A2 (https=) |
| IL (1) | IL292353A (https=) |
| MY (1) | MY207220A (https=) |
| PH (1) | PH12022550963A1 (https=) |
| WO (1) | WO2021086899A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023201306A1 (en) | 2022-04-14 | 2023-10-19 | Invisishield Technologies Ltd. | Compositions for preventing or treating influenza infections |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| WO2005103081A2 (en) | 2004-04-20 | 2005-11-03 | Genmab A/S | Human monoclonal antibodies against cd20 |
| US8257740B1 (en) | 2011-08-15 | 2012-09-04 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| US8246995B2 (en) | 2005-05-10 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| ES2398076T3 (es) | 2006-06-02 | 2013-03-13 | Regeneron Pharmaceuticals, Inc. | Anticuerpos de alta afinidad contra el receptor de IL-6 humano |
| JP5816170B2 (ja) | 2009-06-26 | 2015-11-18 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 |
| SI2501817T2 (sl) | 2010-02-08 | 2021-09-30 | Regeneron Pharmaceuticals, Inc. | Miš z navadno lahko verigo |
| WO2013114885A1 (en) | 2012-01-31 | 2013-08-08 | Osaka University | Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same |
| KR102228296B1 (ko) * | 2012-03-16 | 2021-03-17 | 리제너론 파마슈티칼스 인코포레이티드 | 히스티딘 공학처리된 경쇄 항체 및 그것을 생성하기 위한 유전자 변형된 비-사람 동물 |
| TWI682941B (zh) | 2013-02-01 | 2020-01-21 | 美商再生元醫藥公司 | 含嵌合恆定區之抗體 |
| US10639370B2 (en) * | 2014-02-04 | 2020-05-05 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| JP6712428B2 (ja) | 2014-02-04 | 2020-06-24 | コントラフェクト コーポレイション | インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法 |
| EA201691945A1 (ru) * | 2014-03-27 | 2017-02-28 | Дженентек, Инк. | Антитела к гемагглютинину вируса гриппа типа b и способы их применения |
| CN119161468A (zh) * | 2014-07-15 | 2024-12-20 | 免疫医疗有限责任公司 | 中和抗乙型流感抗体及其用途 |
| TWI702229B (zh) * | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| CN113480640B (zh) | 2015-06-01 | 2024-07-30 | 免疫医疗有限责任公司 | 中和抗流感结合分子及其用途 |
| US10696736B2 (en) * | 2015-06-03 | 2020-06-30 | Xiamen University | Broad-spectrum monoclonal anti-flu B antibody and uses thereof |
| CA3023143A1 (en) | 2016-06-15 | 2017-12-21 | Icahn School Of Medicine At Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
| WO2018187706A2 (en) | 2017-04-07 | 2018-10-11 | Icahn School Of Medicine At Mount Sinai | Anti-influenza b virus neuraminidase antibodies and uses thereof |
| KR102820941B1 (ko) * | 2018-01-26 | 2025-06-16 | 리제너론 파마슈티칼스 인코포레이티드 | 인플루엔자 헤마글루티닌에 대한 인간 항체 |
-
2020
- 2020-10-28 CN CN202080084529.XA patent/CN114761428A/zh active Pending
- 2020-10-28 KR KR1020227016672A patent/KR20220088446A/ko active Pending
- 2020-10-28 BR BR112022007923A patent/BR112022007923A2/pt unknown
- 2020-10-28 IL IL292353A patent/IL292353A/en unknown
- 2020-10-28 CA CA3153944A patent/CA3153944A1/en active Pending
- 2020-10-28 MY MYPI2022002059A patent/MY207220A/en unknown
- 2020-10-28 AU AU2020374878A patent/AU2020374878B2/en active Active
- 2020-10-28 PH PH1/2022/550963A patent/PH12022550963A1/en unknown
- 2020-10-28 EP EP20811191.4A patent/EP4051707A1/en active Pending
- 2020-10-28 US US17/082,375 patent/US11773156B2/en active Active
- 2020-10-28 WO PCT/US2020/057635 patent/WO2021086899A1/en not_active Ceased
- 2020-10-28 JP JP2022523575A patent/JP7611908B2/ja active Active
-
2022
- 2022-04-27 CO CONC2022/0005281A patent/CO2022005281A2/es unknown
- 2022-04-27 CL CL2022001067A patent/CL2022001067A1/es unknown
-
2023
- 2023-08-21 US US18/453,207 patent/US20240083983A1/en active Pending
-
2025
- 2025-11-21 AU AU2025271140A patent/AU2025271140A1/en active Pending